SCHEMBL23819139

SCHEMBL23819139

COC(=O)[C@H](C)NCOC[C@@]1(C#N)O[C@@H](c2ccc3c(/N=C/N(C)C)ncnn23)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26334230 0.92 — —
SCHEMBL23819251 0.89 — —
SCHEMBL23818894 0.86 POLRMT (0.34) —
SCHEMBL23803296 0.85 BTN3A1 (0.34) —
SCHEMBL26331358 0.85 BTN3A1 (0.34) —
SCHEMBL23803298 0.85 BTN3A1 (0.34) —
SCHEMBL25392443 0.84 — —
SCHEMBL26334248 0.83 — —
SCHEMBL23818863 0.82 POLRMT (0.33) —
SCHEMBL25390146 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback